Imcare Biotech Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $153K

  • Investors
  • 1

Imcare Biotech General Information

Description

Developer of diagnostic and pharmaceutical products designed to be used for the treatment of liver-related illnesses. The company develops diagnostic biomarkers and developmental drugs for liver diseases such as hepatocellular carcinoma and intrahepatic cholangiocarcinoma, enabling doctors to diagnose and treat liver-related illnesses.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3805 Old Easton Road
  • Doylestown, PA 18902
  • United States
+1 (215)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 3805 Old Easton Road
  • Doylestown, PA 18902
  • United States
+1 (215)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Imcare Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 14-Jul-2023 $153K Completed Generating Revenue
5. Later Stage VC 13-Apr-2022 Completed Generating Revenue
4. Later Stage VC 27-Jul-2021 Completed Generating Revenue
3. Angel (individual) 12-Mar-2020 Completed Generating Revenue
2. Grant 01-Apr-2015 $2.24M Completed Startup
1. Grant 01-Sep-2012 $1.42M Completed Startup
To view Imcare Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Imcare Biotech Patents

Imcare Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026012693-A Epitope of anti-serine protease inhibitor kazal (spik) antibody Pending 11-Sep-2019
CA-3150538-A1 Epitopes of anti-serine protease inhibitor kazal (spik) antibodies Pending 11-Sep-2019
EP-4028132-A1 Epitopes of anti-serine protease inhibitor kazal (spik) antibodies Pending 11-Sep-2019
US-20240043512-A1 Epitopes of anti-serine protease inhibitor kazal (spik) antibodies Inactive 11-Sep-2019
WO-2021050217-A1 Epitopes of anti-serine protease inhibitor kazal (spik) antibodies Inactive 11-Sep-2019 C07K16/38
To view Imcare Biotech’s complete patent history, request access »

Imcare Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Imcare Biotech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Science Foundation Innovation Corps Program Accelerator/Incubator
To view Imcare Biotech’s complete investors history, request access »

Imcare Biotech FAQs

  • When was Imcare Biotech founded?

    Imcare Biotech was founded in 2011.

  • Where is Imcare Biotech headquartered?

    Imcare Biotech is headquartered in Doylestown, PA.

  • What is the size of Imcare Biotech?

    Imcare Biotech has 10 total employees.

  • What industry is Imcare Biotech in?

    Imcare Biotech’s primary industry is Drug Discovery.

  • Is Imcare Biotech a private or public company?

    Imcare Biotech is a Private company.

  • What is Imcare Biotech’s current revenue?

    The current revenue for Imcare Biotech is .

  • How much funding has Imcare Biotech raised over time?

    Imcare Biotech has raised $4.26M.

  • Who are Imcare Biotech’s investors?

    National Science Foundation Innovation Corps Program has invested in Imcare Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process